TY - JOUR
T1 - Mechanisms of butylidenephthalide for twitch facilitation in electrically stimulated mouse vas deferens
AU - Shih, Chung Hung
AU - Chen, Chi Ming
AU - Ko, Wun Chang
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Context: The rhizome of Ligusticum chuaxiong Hort. (Umbelliferae) has been used by Chinese for several thousand years. Its main constituent, butylidenephthalide (Bdph), was proved to be active in inhibiting rat uterine contractions induced by prostaglandin F2α and was reported to be a nonspecific antispamodic and a blocker of voltage-dependent Ca2+ channels (VDCCs). Objectives: The present study investigates the mechanisms of Bdph for twitch facilitation in ICR mouse vas deferens (MVD). Materials and methods: Electrical field stimulation (EFS, supramaximal voltage ranging from 60–90 V, 1ms, 0.2 Hz) was applied to the isolated MVD in Krebs solution. Interactions between Bdph (50 μM) and calcium antagonist (verapamil, diltiazem or aspaminol) on the EFS-evoked twitch responses were determined. The number of experiments was 3–18. Results: Bdph (50 μM)-induced twitch facilitations from 100 to 391.9% were unrelated to activation of postjunctional cholinergic or adrenergic receptors. Verapamil and Bdph unabolished the twitch facilitation each other. Diltiazem unabolished the Bdph-induced twitch facilitation. In contrast, Bdph abolished those induced by diltiazem. Aspaminol at 20 μM abolished the Bdph-induced twitch facilitation. In contrast, Bdph abolished those induced by aspaminol. Tetraethylammonium and 4-aminopyridine, the K+ channel blockers, significantly augmented the Bdph-induced twitch facilitation. Discussion and conclusions: Bdph may bind to the different, more and same subtypes of VDCCs from verapamil, than diltiazem, and as aspaminol does on prejunctional membrane, respectively. Besides a blocker of VDCCs, Bdph may be a blocker of K+ channels on prejunctional membrane. Thus, Bdph depolarized the membrane and facilitated the cumulative Ca2+-induced twitch responses.
AB - Context: The rhizome of Ligusticum chuaxiong Hort. (Umbelliferae) has been used by Chinese for several thousand years. Its main constituent, butylidenephthalide (Bdph), was proved to be active in inhibiting rat uterine contractions induced by prostaglandin F2α and was reported to be a nonspecific antispamodic and a blocker of voltage-dependent Ca2+ channels (VDCCs). Objectives: The present study investigates the mechanisms of Bdph for twitch facilitation in ICR mouse vas deferens (MVD). Materials and methods: Electrical field stimulation (EFS, supramaximal voltage ranging from 60–90 V, 1ms, 0.2 Hz) was applied to the isolated MVD in Krebs solution. Interactions between Bdph (50 μM) and calcium antagonist (verapamil, diltiazem or aspaminol) on the EFS-evoked twitch responses were determined. The number of experiments was 3–18. Results: Bdph (50 μM)-induced twitch facilitations from 100 to 391.9% were unrelated to activation of postjunctional cholinergic or adrenergic receptors. Verapamil and Bdph unabolished the twitch facilitation each other. Diltiazem unabolished the Bdph-induced twitch facilitation. In contrast, Bdph abolished those induced by diltiazem. Aspaminol at 20 μM abolished the Bdph-induced twitch facilitation. In contrast, Bdph abolished those induced by aspaminol. Tetraethylammonium and 4-aminopyridine, the K+ channel blockers, significantly augmented the Bdph-induced twitch facilitation. Discussion and conclusions: Bdph may bind to the different, more and same subtypes of VDCCs from verapamil, than diltiazem, and as aspaminol does on prejunctional membrane, respectively. Besides a blocker of VDCCs, Bdph may be a blocker of K+ channels on prejunctional membrane. Thus, Bdph depolarized the membrane and facilitated the cumulative Ca2+-induced twitch responses.
KW - Adrenergic prejunctional membrane
KW - Potassium channel blocker
KW - Voltagedependent calcium channel blocker
UR - http://www.scopus.com/inward/record.url?scp=85055700486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055700486&partnerID=8YFLogxK
U2 - 10.1080/13880209.2018.1495749
DO - 10.1080/13880209.2018.1495749
M3 - Article
C2 - 30122096
AN - SCOPUS:85055700486
SN - 1388-0209
VL - 56
SP - 378
EP - 387
JO - Pharmaceutical Biology
JF - Pharmaceutical Biology
IS - 1
ER -